PLAUR and Hepatic fibrosis: The establishment of a mouse model of liver fibrosis treated with CAR-T cells engineered to recognize uPAR revealed the effectiveness of this treatment in diseases related to the accumulation of SCs in tissues, such as liver fibrosis.